Jared S. Hopkins
@JaredSHopkins
Followers
6K
Following
3K
Media
706
Statuses
17K
Scoop: Drugmaker Mallinckrodt is talking to hedge funds that lent it money about a plan to file for bankruptcy and avoid paying $1 billion it owes to opioid victims https://t.co/FoczV33AER via @gladstonea @ajsaeedy
wsj.com
Drugmaker Mallinckrodt is talking to hedge funds about filing for bankruptcy and avoiding payments intended to help people addicted to opioids.
4
1
18
17 Weeks. I took a turn at writing some about Evan in today's print WSJ page devoted to him. check it out here Free Evan. #IStandWithEvan
https://t.co/27Skfvd0oN
4
47
79
Here is a link for the next 24 hours of @WSJ reporter Evan Gershkovich’s colleagues, family and friends reading his journalism - please tune in often to discover his work and share with the world #IStandWithEvan
0
3
9
The first drug to protect all infants from potentially deadly RSV infection has been approved by U.S. drug regulators, called Beyfortus from @sanofi
wsj.com
While the virus often leads to mild, coldlike symptoms, it is the leading cause of hospitalization of infants in the U.S.
1
2
9
Drugs Like Ozempic and Wegovy from @novonordisk created an overnight gold rush. Companies with next gen drugs and diagnostics want a piece of weight loss biz, which is quickly maturing into a booming segment like that of oncology and heart drugs
wsj.com
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago.
1
0
0
Departing @CDCgov Director @RWalensky has a last message for the American public: Be on guard against misinformation and the politicization of science https://t.co/YfQafIQz7k from @sarahtoy17
wsj.com
Stepping down after 2 1/2 years, Dr. Rochelle Walensky says that public health shouldn’t fall along partisan lines and that the public should be wary of misinformation.
0
1
3
New: Bausch + Lomb’s new chief executive, @brentlsaunders , one of the industry’s biggest deal makers, has reached agreement to pay Novartis $1.75 billion for a dry-eye treatment
wsj.com
Eye-care company agreed to pay $1.75 billion for Novartis’s dry-eye treatment Xiidra.
0
4
12
The next Covid vaccine booster will probably target a single strain of the virus, likely one of the Omicron offshoots known as XBB now circulating widely in the U.S., w/@l_e_whyte
wsj.com
Health authorities and vaccine makers are moving toward targeting the next shot on a form of the XBB strain that is now circulating widely in the U.S.
2
4
5
It has been six weeks since our colleague Evan Gershkovich was arrested and unjustly imprisoned in Russia. Please join us in calling for his release. #IStandWithEvan #FreeEvan #JournalismIsNotACrime
Wall Street Journal reporter Evan Gershkovich was detained in Russia on March 29 during a reporting trip and remains in prison. We’re offering resources for those who want to show their support for him. #IStandWithEvan
https://t.co/ll83UMXlp5
2
3
7
Six weeks. He should be free--six weeks ago. #IStandwithEvan #FreeEvan #JournalismIsNotACrime Evan Gershkovich ‘Belongs in This Newsroom’: WSJ Journalists Speak Out https://t.co/Yr2Nm1YSWJ
0
1
2
New research finds that the legendary husky Balto, who helped inspire the Iditarod Trail Sled Dog Race, had healthier genes than dogs of today, reports @AylinWoodward
wsj.com
The husky that helped save an Alaskan town and inspire the Iditarod race had genes which probably helped him survive the extreme environment.
0
0
5
NEW on @axios: The top brass at @wsj @washingtonpost @nytimes will run a joint letter as a full-page, color ad in all three of their papers tomorrow urging support from the Biden Administration in fighting for the release of Evan Gershkovich. Ad below: https://t.co/gMYcAXSSqn
102
650
2K
Cancer drug Keytruda has been a gold mine for Merck, but its patent is running out, and its track record of testing combination therapies is lackluster: more than 20 late-stage failures and at least 66 early\mid-stage studies that weren't moved forward
wsj.com
The company needs combinations of drugs to extend Keytruda sales after the patent expires.
0
0
4
Kaiser Permanente, a large provider of health insurance and medical treatment, is planning to acquire hospital owner Geisinger in a deal aiming to jumpstart a new national healthcare player https://t.co/8uuwxdikGu via @WSJ
wsj.com
The combined nonprofit will aim to add more hospital systems and become a national healthcare player.
1
8
21
Keytruda has been a gold mine for Merck—but the cancer drug’s patent is running out, and the company has struck out on many prospective new uses with combinations
wsj.com
The company needs combinations of drugs to extend Keytruda sales after the patent expires.
1
0
3
Never had allergies before? Why you might feel like you do this year
wsj.com
Pollen season is starting earlier and hitting harder, irritating even people who don’t usually suffer.
0
0
0
A U.S. diplomat demanded Moscow free WSJ reporter Evan Gershkovich and another detained American at a U.N. meeting led by her Russian counterpart
0
0
0
Weight-loss drugmakers are lobbying Congress to grant them access to a monster payday for their blockbuster treatments: Medicare coverage https://t.co/41HpCRvxFo via @l_e_whyte
0
1
2
Florida surgeon general altered key findings in study on Covid-19 vaccine safety https://t.co/2j8sHZaHrS via @politico
politico.com
Joseph Ladapo defended the move, saying revisions are a normal part of assessing such analysis.
0
2
5
Deep dive into the massive cuts and demise of Lee-owned Buffalo News by @angelanfu .
poynter.org
Lee has cut budgets, pushed out veterans and outsourced design and print production at a paper that had been spared the worst of the industry’s decline.
0
0
1